Data as of Sep 22
| +0.18 / +2.18%|
The 4 analysts offering 12-month price forecasts for Derma Sciences Inc have a median target of 17.38, with a high estimate of 18.00 and a low estimate of 14.00. The median estimate represents a +105.86% increase from the last price of 8.44.
The current consensus among 4 polled investment analysts is to Buy stock in Derma Sciences Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.